BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 36332384)

  • 1. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliposomes for oral delivery of total biflavonoids extract from
    Chen B; Wang X; Lin D; Xu D; Li S; Huang J; Weng S; Lin Z; Zheng Y; Yao H; Lin X
    Int J Nanomedicine; 2019; 14():6691-6706. PubMed ID: 31692515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved solubility, dissolution rate, and oral bioavailability of main biflavonoids from
    Chen B; Wang X; Zhang Y; Huang K; Liu H; Xu D; Li S; Liu Q; Huang J; Yao H; Lin X
    Drug Deliv; 2020 Dec; 27(1):309-322. PubMed ID: 32037895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delicaflavone induces apoptosis via mitochondrial pathway accompanying G2/M cycle arrest and inhibition of MAPK signaling cascades in cervical cancer HeLa cells.
    Yao W; Lin Z; Wang G; Li S; Chen B; Sui Y; Huang J; Liu Q; Shi P; Lin X; Liu Q; Yao H
    Phytomedicine; 2019 Sep; 62():152973. PubMed ID: 31177019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.
    Uehara T; Eikawa S; Nishida M; Kunisada Y; Yoshida A; Fujiwara T; Kunisada T; Ozaki T; Udono H
    Int Immunol; 2019 Mar; 31(4):187-198. PubMed ID: 30508092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
    Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
    Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
    Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy.
    Mo W; Liu S; Zhao X; Wei F; Li Y; Sheng X; Cao W; Ding M; Zhang W; Chen X; Meng L; Yao S; Diao W; Wei H; Guo H
    Adv Healthc Mater; 2023 Aug; 12(21):e2300191. PubMed ID: 37031357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
    Khan ANH; Emmons TR; Magner WJ; Alqassim E; Singel KL; Ricciuti J; Eng KH; Odunsi K; Tomasi TB; Lee K; Abrams SI; Mesa C; Segal BH
    Cancer Immunol Immunother; 2022 Oct; 71(10):2355-2369. PubMed ID: 35166871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway.
    Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X
    J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.
    Perez-Penco M; Lara de la Torre L; Lecoq I; Martinenaite E; Andersen MH
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38417917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
    Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
    J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response.
    Park JA; Wang L; Cheung NV
    J Hematol Oncol; 2021 Sep; 14(1):142. PubMed ID: 34496935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Distribution, Excretion, and Interaction With Human Serum Albumin of Total Bioflavonoid Extract From
    Chen B; Xu D; Li Z; Jing Y; Lin L; Li S; Huang L; Huang X; Liu A; Lin X; Yao H
    Front Pharmacol; 2022; 13():849110. PubMed ID: 35571075
    [No Abstract]   [Full Text] [Related]  

  • 19. Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell Therapies.
    Luo W; Napoleon JV; Zhang F; Lee YG; Wang B; Putt KS; Low PS
    Front Immunol; 2022; 13():816761. PubMed ID: 35250995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.